Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.00053 | 1 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.00032 | 1 |